Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines

McCubrey, James A.2022-01-312022-01-312020-06-031945-4589http://hdl.handle.net/10342/9582en-USTP53rapamycincollagenInfluences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell linesArticle10.18632/aging.103377